To assess the correlation between the cryopreservation duration of UCB and clinical hematopoietic recovery, 171 patients with acute leukemia who underwent UCB transplantation with more than 3 × 105 CD34+ cells/kg were analyzed (Supplemental Figure 4I and Supplemental Table 1). This evidence concerns the gene CD34 and acute leukemia.